Vasculitishttps://en.wikipedia.org/wiki/Vasculitis
☆ I dtorthaí 2022 Stiftung Warentest ón nGearmáin, ní raibh sástacht na dtomhaltóirí le ModelDerm ach beagán níos ísle ná mar a bhí le comhairliúchán teileamhíochaine íoctha. Purpura
Henoch schonlein purpura
relevance score : -100.0%
References An aetiological & clinicopathological study on cutaneous vasculitis 22382191 NIH
Of the 61 patients studied, hypersensitivity vasculitis (HSV) [23 (37.7%)] and Henoch Schonlein purpura (HSP) [16 (26.2%)] were the two most common forms. Systemic involvement was seen in 32 (52.45%) patients. Drugs were implicated in 12 (19.7%) cases, infections in 7 (11.4%) and connective tissue disorders in 4 (6.5%) cases. No association was seen between history of drug intake and tissue eosinophilia and also between histologically severe vasculitis and clinical severity.
Leukocytoclastic Vasculitis 29489227 NIH
Is cineál athlasadh craiceann é Leukocytoclastic vasculitis a dhéanann difear do shoithí beaga fola i sraitheanna domhain an chraiceann. Is féidir leis tarlú gan aon chúis ar eolas nó a bheith nasctha le hionfhabhtuithe, siadaí, galair uath-imdhíonachta, nó cógais. I measc na gcomharthaí tipiciúla tá spotaí dearga nó corcra ar na cosa, rannpháirtíocht soithí beaga, agus i thart ar 30 faoin gcéad de na cásanna, déantar difear do chodanna eile den chorp freisin. Glanann formhór na gcásanna ina n-aonar laistigh de chúpla seachtain go mí. Athraíonn an chóireáil bunaithe ar cé chomh dian is atá sé, ó corticosteroidí béil a laghdú de réir a chéile go dtí úsáid a bhaint as drugaí eile a íslíonn athlasadh gan stéaróidigh.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.
○ Diagnosis
D'fhéadfadh feabhas a chur ar vasculitis teoranta don chraiceann le himeacht ama. Mar sin féin, féadfar tástálacha fola agus fuail a dhéanamh chun neamhoird sistéamach nó uath-imdhíonachta a bhrath.
○ Cóireáil - Drugaí thar an gcuntar
Má tá vasculitis teoranta don chraiceann gan ionradh ar orgáin eile, d’fhéadfaí ointment steroid a úsáid.
#OTC steroid ointment